Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Precigen Entered Into A Credit Facility Agreement With Pharmakon Advisors For Up $125M In Non-Dilutive Funding

Author: Benzinga Newsdesk | September 03, 2025 06:05am

The credit facility provides Precigen with up to $125 million committed across two tranches, subject to the terms and conditions of the agreement:

  • The first tranche of $100 million was funded at closing.
  • A second tranche of $25 million can be drawn at Precigen's discretion through March 31, 2027, subject to certain conditions.

Posted In: PGEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist